NUVATION BIO INC (NUVB)

US67080N1019 - Common Stock

3.32  -0.09 (-2.64%)

After market: 3.32 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
99.82M112.33M93.32M43.55M32.10M
Research and Development
71.29M80.52M69.04M32.60M25.11M
Selling, General, and Administrative Expenses
28.53M31.82M24.28M10.95M6.99M
Operating Income
-99.82M-112.33M-93.32M-43.55M-32.10M
Interest Income/Expense
24.47M6.22M2.88M2.16M-1.32M
Other Income/Expense
-452.00K9.32M3.59M-270.00K-140.00K
Non Recurring Items
N/A-7.40MN/AN/AN/A
Income Before Taxes
-75.80M-104.20M-86.85M-41.66M-33.55M
Income Tax
0.000.000.000.00N/A
Net Income
-75.80M-104.20M-86.85M-64.28M-33.55M
EBITDA
-99.60M-112.13M-93.14M-43.45M-32.09M
 
Per Share Data
EPS Diluted Total Ops
-0.35-0.48-0.44-0.30-0.15
Non GAAP EPS
-0.34-0.48-0.44N/AN/A
 
Statistics

All data in USD

Charts